Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
JDD coverage and what to read next JDD has published an increasing number of articles that examine the connections between GLP-1 therapies and skin health. As GLP-1 receptor agonists gain…
From the Vault: Patient reviews, clinical experience, and original medical content outweigh social media presence for most patients From the JDD Vault, this cross sectional survey provides timely insight into…
Practical insights on topical therapy, pruritus, psoriasis, and off label strategies with Dr. Adam Friedman From steroid safety to itch management to creative on and off label topical strategies and…
JDD analysis highlights racial gaps in JAK inhibitor dermatology trials Have you caught this new JDD, analysis on JAK inhibitor trials? Dermatologists and clinical investigators will likely find this review relevant…
JDD alert: Must-read study reports an association between lichen planopilaris and scalp non-melanoma skin cancer A new JDD report analyzes global TriNetX data from 2005 to 2025 and compares patients…
Guest: Dr. Rachel Sheskier Steroids: indispensable, unpredictable, and, when it comes to endocrinology, often hiding in plain sight. In this episode of the JDD Podcast, Dr. Adam Friedman continues the…